跳至主要内容
临床试验/NCT04538820
NCT04538820Unknown4 期

Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients

Diskapi Yildirim Beyazit Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
150
试验地点
1
主要终点
postoperative nausea and vomiting (PONV)

研究概览

简要总结

compare the effectiveness of different doses of dexamethasone used for postoperative nausea and vomiting prophylaxis in obese patients and in normal weight patients.

详细描述

compare the effectiveness of different doses of dexamethasone used for postoperative nausea and vomiting prophylaxis in obese patients.

compare the effectiveness of dexamethasone given in 4 mg and 8 mg doses in obese patients with 4 mg doses of dexamethasone in normal weight patients.

4 mg iv dexamethasone will be administered to normal weight patients at induction of anesthesia. This group will be classified as the control group. In obese patients (BMI>30 kg/m2), one group will receive 4 mg dexamethasone and other group will receive 8 mg dexamethasone at induction.

Patients will receive general anesthesia with volatile anesthetics and tramadol will be administered IV at the end of surgery.

Postoperative nausea and vomiting, postoperative pain, blood glucose, wound infection, time to oral intake, hospital stay will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • High risk patients for postoperative nausea and vomiting:
  • No smoking
  • BMI =18.5-24.9 for control group
  • BMI >30 for other groups
  • undergo laparoscopic cholecystectomy

排除标准

  • Diabetes mellitus

研究组 & 干预措施

control

Active Comparator

patients with BMI=18.5-24.9 kg/m2 will be received 4 mg dexamethasone at induction of anesthesia for postoperative nausea and vomiting prophylaxis.

干预措施: Dexamethasone 4 mg IV-control (Drug)

4 mg

Active Comparator

patients with BMI>30 kg/m2 will be received 4 mg dexamethasone at induction of anesthesia for postoperative nausea and vomiting prophylaxis.

干预措施: Dexamethasone 4 mg IV (Drug)

8 mg

Active Comparator

patients with BMI>30 kg/m2 will be received 8 mg dexamethasone at induction of anesthesia for postoperative nausea and vomiting prophylaxis.

干预措施: Dexamethasone 8 mg IV (Drug)

结局指标

主要结局

postoperative nausea and vomiting (PONV)

时间窗: PONV scores wİll be record during the first 24 hours

The primary outcome is the overall incidence of PONV during the first 24 h, defined as any episode of vomiting or nausea.Nausea will be measured using an 11-point verbal rating scale (VRS) running from 0 (no nausea) to 10 (the worst nausea imaginable). We will define severe PONV as nausea with a score of at least 4 on the VRS, or vomiting.

次要结局

  • Length of Hospital Stay(during the first 24 hours)
  • postoperative pain: 11-point VRS(Pain will be assessed during the first 24 hours)
  • blood glucose(at 6 and 10 hours after administration of dexamethasone)
  • wound infection(postoperative 30th day)
  • oral intake(during the first 24 hours)

研究者

发起方
Diskapi Yildirim Beyazit Education and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Bahar SAKIZCI UYAR

medical doctor

Diskapi Yildirim Beyazit Education and Research Hospital

研究点 (1)

Loading locations...

相似试验

Dexamethasone Dose for Postoperative Nausea and... | 临床试验